Sciton Inc, Image Hair Removal Laser
Pre-Market Notification
NOV 05 2001
510K Summary Statement for the
Sciton Inc Image Hair Removal Laser
kKOlasys Q
en
1. General Information
Submitter: Sciton Inc
845 Commercial Street
Palo Alto, CA 94303
Contact Person Peter Ailen
Summary Preparation Date August 7, 2001
2. Names
Device Names Image, Image Hair Removal Laser
and Image Long Pulse Nd:YAG
Primary Classification Names: Laser Powered Surgical Instrument
for use in General, Plastic Surgery
and Dermatoigy in accordance with
21CFR 878-4810.79-GEX
3. Predicated Devices
The product specifications, functionality, indications for use, and
treatment parameters of the Sciton Inc Hair Removal Laser are the same
or very similar to the following legally market lasers: :
Altus Medical, Nd:YAG Aesthetic Laser
Laserscope, Long Pulse Nd:YAG
510K Image Hair Removal Laser
Sciton Inc
Section K-1 (Rev A 8-7-01)

Sciton Inc, Image Hair Removal Laser
Pre-Market Notification
4. Product Description
The Sciton Inc, Hair Removal Laser is a long pulsed, solid state infrared
laser. It is intended to deliver laser energy for use in surgical and
aesthetic applications requiring the of Removal of Hair folicles. The Hair
Removal Laser produces a beam of infrared light at a wavelength of
1064nm. The system consists of:
A laser console
Internal computer
Control panel and display
Articulated Arm
Footswitch with optional handswitch
Scanner and Handpieces with cooling capability
5. Indications for Use
The Sciton, Inc. Image Hair Removal Laser is intended for use in surgical
and aesthetic applications requiring selective photothermolysis of target
chromophores in soft tissue in general and plastic surgery and
dermatology. In addition it is intended to effect stable long term, or
permanent hair reduction through selective targeting of melanin in hair
follicles (where permanent hair reduction is defined as a long term stable
reduction in the number of hairs growing after a treatment regimen)
6. Rationale for Substantial Equivalence
The Sciton Inc Hair Removal Laser shares the same indications for use,
similar design features (including wavelength, active medium, cooling
system and controls), similar functional features (including pulse duration
and fluence), and similar treatment parameters of other marketed long
pulse Nd:YAG laser systems (as opposed to Q-switched lasers). Therfore
the Sciton Inc Hair Removal Laser is substantially equivalent to the Altus
Medical Laser Nd:YAG Aesthetic Laser , Laserscope
510K Image Hair Removal Laser
Sciton Inc
Section K-2. (Rev A 8-7-01)

VIC,
if DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
& I I PT ae
“oe . Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850

Mr. Peter Allen NOV 05 2001
Director, Regulatory Affairs
Sciton, Inc.
845 Commercial Street
Palo Alto, California 94303
Re: K012552

Trade/Device Name: Sciton Image Hair Removal System

Regulation Number: 878.4810

Regulation Name: Laser surgical instrument for use in general and

plastic surgery and in dermatology

Regulatory Class: II

Product Code: GEX

Dated: August 7, 2001

Received: August 8, 2001
Dear Mr. Allen:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other F ederal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation contro! provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Mr. Peter Allen
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and
additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of
Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of
your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the
regulation entitled, "Misbranding by reference to premarket notification” (21CFR Part 807.97).
Other general information on your responsibilities under the Act may be obtained from the
Division of Small Manufacturers, International and Consumer Assistance at its toll-free number
(800) 638-2041 or (301) 443-6597 or at its Internet address
http://www. fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
S cso WD alk. t AA
Celia M. Witten, Ph.D., M.D.
0. Director
: Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure

05 2001 0 545
NOV FDA Submission Cover Sheet | 2 A
510(K) Number (if known): kK 0 \ 2 5 C a
Device Name: Sciton Image Hair Removal Laser
Indications for Use:
The Sciton, Inc. Image Hair Removal Laser is intended for use in surgical and
aesthetic applications _ requiring selective photothermolysis of target
chromophores in soft tissue in general and plastic surgery and dermatology. In /
addition it is intended to effect stable long term, or permanent hair reduction :
through selective targeting of melanin in hair follicles (where permanent hair ” :
reduction is defined as a long term stable reduction in the number of hairs ~~ :
growing after a treatment regimen) .
(PLEASE DO NOT WRITE BELOW THIS LINE — CONTINUE ON ANOTHER PAGE IF
NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use “A OR Over The Counter Use
(Per 21CFR 801)
a
(Division Sign-Off) .
Division of General, Restorative
and Neurological Devices
‘101 255 2510(k) Number _ kor2ss*
Section A-1 (Rev A 8-7-01)

